Pfizer breaks ground on new biologics clinical manufacturing facility

By Melissa Fassbender contact

- Last updated on GMT

A mock-up of the new Andover, MA-based biologics clinical manufacturing facility. (Image: Pfizer)
A mock-up of the new Andover, MA-based biologics clinical manufacturing facility. (Image: Pfizer)

Related tags: Disposable, Investment

Pfizer broke ground on its new Andover, MA-based biologics clinical manufacturing facility this week, which will feature single-use and disposable technologies.

The company will invest more than $200m in development of the 175,000 sq. ft. facility, which is expected to be operational by January 2019.

According to Pfizer, the new clinical manufacturing facility was designed with five independent manufacturing suites.

The facility will feature single-use bioreactors and disposable process technologies and will be fully enabled to support next generation manufacturing.

The Andover campus currently includes seven buildings housing laboratories, clinical and commercial manufacturing suites, and other support areas.

The campus also features a multiproduct manufacturing facility.

As part of the new investment, Pfizer will hire approximately 75 new employees to support clinical manufacturing.

Related news

Show more

Related products

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars